1. Morrissey, Samantha M, Zhang, Fan, Ding, Chuanlin, Huang, Jian, Yan, Jun. 2021. Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming. In Cell metabolism, 33, 2040-2058.e10. doi:10.1016/j.cmet.2021.09.002. https://pubmed.ncbi.nlm.nih.gov/34559989/
2. Xu, Jia-Ze, Jiang, Jun-Jie, Xu, Hao-Jie, Liu, Zheng-Chuang, Hu, Zhi-Ming. 2021. High expression of YKT6 associated with progression and poor prognosis of hepatocellular carcinoma. In Scandinavian journal of gastroenterology, 56, 1349-1354. doi:10.1080/00365521.2021.1961305. https://pubmed.ncbi.nlm.nih.gov/34396876/
3. Yang, Zongcheng, Yan, Guangxing, Zheng, Lixin, Fu, Yue, Xu, Xin. 2021. YKT6, as a potential predictor of prognosis and immunotherapy response for oral squamous cell carcinoma, is related to cell invasion, metastasis, and CD8+ T cell infiltration. In Oncoimmunology, 10, 1938890. doi:10.1080/2162402X.2021.1938890. https://pubmed.ncbi.nlm.nih.gov/34221701/
4. Liu, Jiamin, Zhang, Qiang, He, Ling, Wang, Yixuan, Xie, Ping. 2025. Pan-Cancer Analysis Identifies YKT6 as a Prognostic and Immunotherapy Biomarker, with an Emphasis on Cervical Cancer. In OncoTargets and therapy, 18, 107-127. doi:10.2147/OTT.S491310. https://pubmed.ncbi.nlm.nih.gov/39867862/
5. Ma, Mengqi, Ganapathi, Mythily, Zheng, Yiming, Chung, Wendy K, Bellen, Hugo J. 2024. Homozygous missense variants in YKT6 result in loss of function and are associated with developmental delay, with or without severe infantile liver disease and risk for hepatocellular carcinoma. In Genetics in medicine : official journal of the American College of Medical Genetics, 26, 101125. doi:10.1016/j.gim.2024.101125. https://pubmed.ncbi.nlm.nih.gov/38522068/
6. Ji, Jie, Yu, Yiping, Wu, Shaowen, Weng, Jingwei, Wang, Wenning. 2023. Different conformational dynamics of SNARE protein Ykt6 among yeast and mammals. In The Journal of biological chemistry, 299, 104968. doi:10.1016/j.jbc.2023.104968. https://pubmed.ncbi.nlm.nih.gov/37380075/